Mordwinkin Nicholas Michael has filed 5 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 275000 shares of Kezar Life Sciences, Inc. ($KZR) on January 07, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2024 | Kezar Life Sciences, Inc. | $KZR | Mordwinkin Nicholas Michael | Chief Business Officer | A | Employee Stock Option (right to buy) | 275000 | $0.00 | 275,000.0000 | 0 | 9999.99% | 0.00% |
| July 24, 2023 | Kezar Life Sciences, Inc. | $KZR | Mordwinkin Nicholas Michael | Chief Business Officer | D | Employee Stock Option (right to buy) | 185000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 24, 2023 | Kezar Life Sciences, Inc. | $KZR | Mordwinkin Nicholas Michael | Chief Business Officer | A | Employee Stock Option (right to buy) | 185000 | $0.00 | 185,000.0000 | 0 | 9999.99% | 0.00% |
| July 24, 2023 | Kezar Life Sciences, Inc. | $KZR | Mordwinkin Nicholas Michael | Chief Business Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2023 | Kezar Life Sciences, Inc. | $KZR | Mordwinkin Nicholas Michael | Chief Business Officer | A | Employee Stock Option (right to buy) | 185000 | $0.00 | 185,000.0000 | 0 | 9999.99% | 0.00% |